MRNA logo

Moderna (MRNA) Operating Expenses

Annual Operating Expenses

$6.30 B
+$2.26 B+55.98%

31 December 2023

MRNA Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$1.41 B
-$58.00 M-3.95%

30 September 2024

MRNA Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRNA Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+56.0%-9.4%
3 y3 years+512.2%+157.0%
5 y5 years+1075.9%+879.2%

MRNA Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+512.2%-24.9%+157.0%
5 y5 yearsat high+1075.9%-24.9%+945.2%
alltimeall timeat high>+9999.0%-24.9%>+9999.0%

Moderna Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$1.41 B(-3.9%)
June 2024
-
$1.47 B(+9.9%)
Mar 2024
-
$1.34 B(-28.8%)
Dec 2023
$6.30 B(+56.0%)
$1.88 B(+20.5%)
Sept 2023
-
$1.56 B(+7.3%)
June 2023
-
$1.45 B(+2.8%)
Mar 2023
-
$1.41 B(-14.5%)
Dec 2022
$4.04 B(+121.6%)
$1.65 B(+73.1%)
Sept 2022
-
$954.00 M(+29.3%)
June 2022
-
$738.00 M(+6.0%)
Mar 2022
-
$696.00 M(+18.6%)
Dec 2021
$1.82 B(+77.2%)
$587.00 M(+6.9%)
Sept 2021
-
$549.00 M(+36.2%)
June 2021
-
$403.00 M(+41.9%)
Mar 2021
-
$284.00 M(-42.7%)
Dec 2020
$1.03 B(+73.2%)
$496.00 M(+100.8%)
Sept 2020
-
$247.00 M(+63.6%)
June 2020
-
$151.00 M(+11.9%)
Mar 2020
-
$135.00 M(-3.8%)
Dec 2019
$594.00 M(+10.9%)
$140.40 M(-2.6%)
Sept 2019
-
$144.10 M(-6.3%)
June 2019
-
$153.74 M(-1.3%)
Mar 2019
-
$155.76 M(-16.2%)
Dec 2018
$535.78 M(+20.0%)
$185.85 M(+51.7%)
Sept 2018
-
$122.48 M(-0.3%)
June 2018
-
$122.85 M(+17.2%)
Mar 2018
-
$104.86 M(-19.5%)
Dec 2017
$446.33 M(+37.2%)
$130.24 M(>+9900.0%)
Sept 2017
-
$1.04 M(+9.2%)
June 2017
-
$948.90 K(-1.9%)
Mar 2017
-
$967.30 K(+131.7%)
Dec 2016
$325.31 M(+6867.4%)
-
Dec 2016
-
$417.40 K(+327.2%)
Sept 2016
-
$97.70 K(-23.9%)
June 2016
-
$128.40 K(+12.4%)
Mar 2016
-
$114.20 K(-86.1%)
Dec 2015
$4.67 M(+16.1%)
$820.00 K(-26.3%)
Sept 2015
-
$1.11 M(-21.8%)
June 2015
-
$1.42 M(+8.1%)
Mar 2015
-
$1.31 M(+11.5%)
Dec 2014
$4.02 M(+62.1%)
$1.18 M(-26.6%)
Sept 2014
-
$1.61 M(+139.5%)
June 2014
-
$671.00 K(+19.2%)
Mar 2014
-
$563.00 K(-42.4%)
Dec 2013
$2.48 M(-76.2%)
$977.00 K(+44.5%)
Sept 2013
-
$676.00 K(+34.9%)
June 2013
-
$501.00 K(+53.7%)
Mar 2013
-
$326.00 K(-87.5%)
Dec 2012
$10.42 M(-47.4%)
$2.61 M(+93.0%)
Sept 2012
-
$1.35 M(-38.2%)
June 2012
-
$2.19 M(-48.9%)
Mar 2012
-
$4.28 M(+1.2%)
Dec 2011
$19.81 M(-30.4%)
$4.23 M(-12.1%)
Sept 2011
-
$4.81 M(-12.9%)
June 2011
-
$5.52 M(+5.1%)
Mar 2011
-
$5.25 M(+10.2%)
Dec 2010
$28.46 M(+14.0%)
$4.76 M(-58.4%)
Sept 2010
-
$11.46 M(+88.3%)
June 2010
-
$6.08 M(-1.2%)
Mar 2010
-
$6.16 M(+14.9%)
Dec 2009
$24.97 M
$5.36 M(-21.2%)
Sept 2009
-
$6.80 M(+3.1%)
June 2009
-
$6.59 M(+5.9%)
DateAnnualQuarterly
Mar 2009
-
$6.22 M(-49.1%)
Dec 2008
$50.39 M(-30.6%)
$12.24 M(+21.1%)
Sept 2008
-
$10.11 M(-18.0%)
June 2008
-
$12.32 M(-21.7%)
Mar 2008
-
$15.73 M(-15.7%)
Dec 2007
$72.57 M(+26.3%)
$18.67 M(-1.0%)
Sept 2007
-
$18.86 M(+5.5%)
June 2007
-
$17.88 M(+4.2%)
Mar 2007
-
$17.16 M(+8.1%)
Dec 2006
$57.45 M(+39.3%)
$15.87 M(+13.9%)
Sept 2006
-
$13.93 M(+11.4%)
June 2006
-
$12.50 M(-17.5%)
Mar 2006
-
$15.15 M(+40.8%)
Dec 2005
$41.23 M(+37.1%)
$10.76 M(+2.8%)
Sept 2005
-
$10.46 M(+1.7%)
June 2005
-
$10.29 M(+5.9%)
Mar 2005
-
$9.72 M(+33.0%)
Dec 2004
$30.08 M(+19.6%)
$7.30 M(-3.9%)
Sept 2004
-
$7.60 M(+1.6%)
June 2004
-
$7.49 M(-2.6%)
Mar 2004
-
$7.69 M(+13.4%)
Dec 2003
$25.15 M(+16.3%)
$6.78 M(+3.2%)
Sept 2003
-
$6.57 M(-3.3%)
June 2003
-
$6.80 M(+35.8%)
Mar 2003
-
$5.00 M(-25.6%)
Dec 2002
$21.62 M(+85.5%)
$6.72 M(+23.0%)
Sept 2002
-
$5.46 M(+6.5%)
June 2002
-
$5.13 M(+19.1%)
Mar 2002
-
$4.31 M(+32.7%)
Dec 2001
$11.65 M(-21.5%)
$3.25 M(+25.2%)
Sept 2001
-
$2.59 M(-7.3%)
June 2001
-
$2.80 M(-7.3%)
Mar 2001
-
$3.02 M(-40.7%)
Dec 2000
$14.85 M(+5.3%)
$5.08 M(+65.1%)
Sept 2000
-
$3.08 M(-7.3%)
June 2000
-
$3.32 M(-1.3%)
Mar 2000
-
$3.37 M(-32.7%)
Dec 1999
$14.10 M(+38.2%)
$5.00 M(+66.7%)
Sept 1999
-
$3.00 M(+7.1%)
June 1999
-
$2.80 M(-28.2%)
Mar 1999
-
$3.90 M(+5.4%)
Dec 1998
$10.20 M(+3.0%)
$3.70 M(+54.2%)
Sept 1998
-
$2.40 M(-14.3%)
June 1998
-
$2.80 M(+33.3%)
Mar 1998
-
$2.10 M(-32.3%)
Dec 1997
$9.90 M(+607.1%)
$3.10 M(+10.7%)
Sept 1997
-
$2.80 M(+16.7%)
June 1997
-
$2.40 M(+60.0%)
Mar 1997
-
$1.50 M(+36.4%)
Dec 1996
$1.40 M(-64.1%)
-
Sept 1996
-
$1.10 M(-8.3%)
June 1996
$3.90 M(+30.0%)
$1.20 M(+33.3%)
Mar 1996
-
$900.00 K(0.0%)
Dec 1995
-
$900.00 K(0.0%)
Sept 1995
-
$900.00 K(-10.0%)
June 1995
$3.00 M(+233.3%)
$1.00 M(+42.9%)
Mar 1995
-
$700.00 K(0.0%)
Dec 1994
-
$700.00 K(+16.7%)
Sept 1994
-
$600.00 K(+100.0%)
June 1994
$900.00 K
$300.00 K(0.0%)
Mar 1994
-
$300.00 K(+200.0%)
Dec 1993
-
$100.00 K(-66.7%)
Sept 1993
-
$300.00 K

FAQ

  • What is Moderna annual total operating expenses?
  • What is the all time high annual operating expenses for Moderna?
  • What is Moderna annual operating expenses year-on-year change?
  • What is Moderna quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Moderna?
  • What is Moderna quarterly operating expenses year-on-year change?

What is Moderna annual total operating expenses?

The current annual operating expenses of MRNA is $6.30 B

What is the all time high annual operating expenses for Moderna?

Moderna all-time high annual total operating expenses is $6.30 B

What is Moderna annual operating expenses year-on-year change?

Over the past year, MRNA annual total operating expenses has changed by +$2.26 B (+55.98%)

What is Moderna quarterly total operating expenses?

The current quarterly operating expenses of MRNA is $1.41 B

What is the all time high quarterly operating expenses for Moderna?

Moderna all-time high quarterly total operating expenses is $1.88 B

What is Moderna quarterly operating expenses year-on-year change?

Over the past year, MRNA quarterly total operating expenses has changed by -$147.00 M (-9.44%)